Emerald Health Therapeutics Closes Final Tranche Prospectus Sale

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE OR FOR DISSEMINATION IN THE UNITED STATESVANCOUVER, British Columbia, Feb. 14, 2020 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (a??Emeralda??) (TSXV: EMH; OTCQX: EMHTF) has closed the final tranche of its $3,000,000 prospectus offering (the a??Offeringa??), announced in its news release dated January 6, 2020.Pursuant to this final closing, Emerald has issued an aggregate of 2,748,276 units of Emerald (each, a "Unit") at a price of $0.29 per Unit for total gross proceeds of $797,000. The initial tranche of the Offering closed on February 6, 2020 for gross proceeds of $2,203,000.Each Unit consists of one common share of Emerald and one common share purchase warrant (each, a "Warrant"). Each Warrant will entitle the holder thereof to acquire one common share of Emerald (each, a "Warrant Share") at a price of $0.385 per Warrant Share for a period of five years following the closing of the Offering.The Company intends to use the net proceeds of the Offering for general working capital purposes, including the payment of salaries, consulting fees and operating expenses.
See also:
Leave a comment
  • Latest
  • Read
  • Commented
Calendar Content
«     2020    »